Vulvovaginal Candidiasis: Pathogenesis, Diagnosis, and Treatment Strategy

For citation: Bairamova G.R., Amirkhanyan A.S., Chernova V.F. Vulvovaginal Candidiasis: Pathogenesis, Diagnosis, and Treatment Strategy. Doctor.Ru. 2018; 10(154): 32–36. DOI: 10.31550/1727-2378-2018-154-10-32-36
16 November 09:54

Objective of the Review: To evaluate the current understanding of the etiology and pathogenesis of vulvovaginal candidiasis (VVC), as well as specific features of its course and diagnostic and therapeutic options for this condition, based on the results of Russian and foreign studies.

Key Points: VVC is an infection of the vulval and vaginal mucosa, caused by the Candida fungus. Despite the availability of a great number of antifungal agents, treatment of VVC is a challenging task because the causative pathogen is developing resistance to widely used medications. This paper describes the authors’ own experience of using fenticonazole (Lomexin) in the treatment of VVC, which proves its clinical effectiveness.

Conclusion: The choice of treatment strategies for patients with VVC should vary depending on the clinical form of VVC, its severity, predisposing factors, and concomitant diseases. A comprehensive treatment approach and a reasonable choice of antifungal agents for patients with VVC increase the efficacy of treatment and reduce the frequency of recurrences.

G.R. Bairamova — Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Moscow. Е-mail:

A.S. Amirkhanyan — Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Moscow. Е-mail:

V.F. Chernova — Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Moscow. Е-mail:

16 November 09:54
  1. Mills B.B. Vaginitis: beyond the basics. Obstet. Gynecol. Clin. North Am. 2017; 44(2): 159–77
  2. Sobel J.D. Genital candidiasis. Medicine. 2014; 42(7): 364–8
  3. Delaloye J., Calandra T. Invasive candidiasis as a cause of sepsis in the critically ill patient. Virulence. 2014; 5(1): 161–9
  4. Савельева Г.М., Сухих Г.Т., Манухин И.Б., Радзинский В.Е., ред. Гинекология: национальное руководство. М.: ГЭОТАР-Медиа; 2017. 1048 с. [Savel'eva G.M., Sukhikh G.T., Manukhin I.B., Radzinskii V.E., red. Ginekologiya: natsional'noe rukovodstvo. M.: GEOTAR-Media; 2017. 1048 s. (in Russian)]
  5. Серов В.Н., Сухих Г.Т., Прилепская В.Н., Радзинский В.Е. Руководст­во по амбулаторно-поликлинической помощи в акушерстве и гинекологии. М.: ГЭОТАР-Медиа; 2016. 1136 с. [Serov V.N., Sukhikh G.T., Prilepskaya V.N., Radzinskii V.E. Rukovodstvo po ambulatorno-poliklinicheskoi pomoshchi v akusherstve i ginekologii. M.: GEOTAR-Media; 2016. 1136 s. (in Russian)]
  6. Wаchtler B., Wilson D., Haedicke K., Dalle F., Hube B. From attachment to damage: defined genes of Candida albicans mediate adhesion, invasion and damage during interaction with oral epithelial cells. PLoS One. 2011; 6: e17046
  7. Sherry L., Kean R., McKloud E., O'Donnell L.E., Metcalfe R., Jones B.L. et al. Biofilms formed by isolates from recurrent vulvovaginal candidiasis patients are heterogeneous and insensitive to fluconazole. Antimicrob. Agents Chemother. 2017; 61(9): e01065–17
  8. Zordan R., Cormack B. Adhesins on opportunistic fungal pathogens. In: Calderone R.A., Clancy C.J., ed. Candida and candidiasis. Washington: ASM Press; 2012: 243–259
  9. Zhang Y., Li W., Chu M., Chen H., Yu H., Fang C. et al. The AAA ATPase Vps4 plays important roles in Candida albicans hyphal formation and is inhibited by DBeQ. Mycopathologia. 2016; 181(5–6): 329–39
  10. Murciano C., Moyes D.L., Runglall M., Tobouti P., Islam A., Hoyer L.L. et al. Evaluation of the role of Candida albicans agglutinin-like sequence (Als) proteins in human oral epithelial cell interactions. PLoS One. 2012; 7: e33362
  11. Garcia M.C., Lee J.T., Ramsook C.B., Alsteens D., Dufrêne Y.F., Lipke P.N. A role for amyloid in cell aggregation and biofilm formation. PLoS One. 2011; 6: e17632
  12. Nobile C.J., Johnson A.D. Candida albicans biofilms and human disease. Annu Rev. Microbiol. 2015; 69: 71–92
  13. Rane H.S., Hardison S., Botelho C., Bernardo S.M., Wormley F.Jr., Lee S.A. Candida albicans VPS4 contributes differentially to epithelial and muco­sal pathogenesis. Virulence. 2014; 5(8): 810–8
  14. Hong E., Dixit S., Fidel P.L., Bradford J., Fischer G. Vulvovaginal candidiasis as a chronic disease: diagnostic criteria and definition. J. Low Genit. Tract Dis. 2014; 18(1): 31–8
  15. Fox E.P., Nobile C.J. A sticky situation: untangling the transcriptional network controlling biofilm development in Candida albicans. Transcription. 2012; 3(6): 315–22
  16. Nett J.E., Zarnowski R., Cabezas-Olcoz J., Brooks E.G., Bernhardt J., Marchillo K. et al. Host contributions to construction of three device-associated Candida biofilms. Infect. Immun. 2015; 83(12): 4630–8
  17. Zarnowski R., Westler W.M., Lacmbouh G.A., Marita J.M., Bothe J.R., Bernhardt J. et al. Novel entries in a fungal biofilm matrix encyclopedia. MBio. 2014; 5(4): e01333–14
  18. Fox E.P., Cowley E.S., Nobile C.J., Hartooni N., Newman D.K., Johnson A.D. Anaerobic bacteria grow within Candida albicans biofilms and induce biofilm formation in suspension cultures. Curr. Biol. 2014; 24(20): 2411–16
  19. Байрамова Г.Р. Современный взгляд на проблему хронического рецидивирующего вульвовагинального кандидоза. Акушерство и гинекология. 2008; 4: 52–6. [Bairamova G.R. Sovremennyi vzglyad na problemu khronicheskogo retsidiviruyushchego vul'vovaginal'nogo kandidoza. Akusherstvo i ginekologiya. 2008; 4: 52–6. (in Russian)]
  20. Centers for Disease Control (CDC). Sexually Transmitted Diseases Treatment Guidelines, 2015. (дата обращения — 15.02.2018)
  21. Donders G.G., Bellen G., Mendling W. Management of recurrent vulvovaginal candidosis as a chronic illness. Gynecol. Obstet. Invest. 2010; 70(4): 306–21
  22. Байрамова Г.Р. Рецидивирующий вульвовагинальный кандидоз: клиника, диагностика, лечение: Автореф. дис. … докт. мед. наук. М.; 2013. 46 с. [Bairamova G.R. Retsidiviruyushchii vul'vovaginal'nyi kandidoz: klinika, diagnostika, lechenie: Avtoref. dis. … dokt. med. nauk. M.; 2013. 46 s. (in Russian)]
  23. Прилепская В.Н., Мирзабаева А.К., Кира Е.Ф., Гомберг М.А., Апо­лихина И.А., Байрамова Г.Р., ред. Федеральные клинические рекомендации. Диагностика и лечение заболеваний, сопровождающихся патологическими выделениями из половых путей. М.; 2013. 47 с. [Prilepskaya V.N., Mirzabaeva A.K., Kira E.F., Gomberg M.A., Apolikhi­na I.A., Bairamova G.R., red. Federal'nye klinicheskie rekomendatsii. Diagnostika i lechenie zabolevanii, soprovozhdayushchikhsya patolo­gicheskimi vydeleniyami iz polovykh putei. M.; 2013. 47 s. (in Russian)]
  24. Sherrard J., Donders G., White D., Jensen J.S.; European IUSTI. European (IUSTI/WHO) guideline on the management of vaginal discharge. Int. J. STD AIDS. 2011; 22(8): 421–9
  25. Роговская С.И., Бебнева Т.Н., Ткаченко Л.В. Возможности местных форм противогрибковых средств в лечении генитального кандидоза. Акушерство и гинекология. 2015; 11: 121–5. [Rogovs­kaya S.I., Bebneva T.N., Tkachenko L.V. Vozmozhnosti mestnykh form protivogribkovykh sredstv v lechenii genital'nogo kandidoza. Akusherstvo i ginekologiya. 2015; 11: 121–5. (in Russian)]
  26. Иванова И.И., Степанян А.В., Джобава Э.М., Доброхотова Ю.Э. Опыт применения фентиконазола в лечении кандидозного вульвовагинита. Гинекология. 2012; 14(1): 72–4. [Ivanova I.I., Stepanyan A.V., Dzhobava E.M., Dobrokhotova Yu.E. Opyt primeneniya fentikonazola v lechenii kandidoznogo vul'vovaginita. Ginekologiya. 2012; 14(1): 72–4. (in Russian)]
  27. Абакарова П.Р., Прилепская В.Н., Межевитинова Е.А., Байрамо­ва Г.Р., Иванова Е.В. Современные возможности эффективного лечения вульвовагинального кандидоза. Акушерство и гинекология. 2012; 7: 79–82. [Abakarova P.R., Prilepskaya V.N., Mezhevitinova E.A., Bairamova G.R., Ivanova E.V. Sovremennye vozmozhnosti effektivnogo lecheniya vul'vovaginal'nogo kandidoza. Akusherstvo i ginekologiya. 2012; 7: 79–82. (in Russian)]
  28. Малова И.О. Эффективность азоловых препаратов при остром вульвовагинальном кандидозе. Акушерство и гинекология. 2016; 10: 109–14. [Malova I.O. Effektivnost' azolovykh preparatov pri ostrom vul'vovaginal'nom kandidoze. Akusherstvo i ginekologiya. 2016; 10: 109–14. (in Russian)]


30 June 00:00
A New Issue of Doctor.Ru Neurology Psychiatry, Vol. 20, No. 5 (2021), Published

Find original articles and reviews covering various aspects of neurology, psychiatry and the interview with Professor Marina Arkadievna Kinkulkina

28 June 00:00
A New Issue of Doctor.Ru Internal Medicine, Vol. 20, No. 4 (2021), Published

Find original articles and reviews covering various aspects of cardiology, gastroenterology, internal medicine and the interview with Professor Elena Zelikovna Golukhova


3 May 17:06
A New Issue of Doctor.Ru Pediatrics, Vol. 20, No. 3 (2021), Published

Find original articles and reviews covering various aspects of pediatrics and the interview with Professor Evgeny Grigorievich Furman

3 May 17:06
A New Issue of Doctor.Ru Endocrinology, Vol. 20, No. 2 (2021), Published

Find original articles and reviews covering various aspects of endocrinology and the interview with Professor Valentin Viktorovich Fadeev

16 April 11:57
Igor Evgenievich Khatkov joined the American Surgical Association

Igor Evgenievich Khatkov, Head of A. S. Loginov Moscow Clinical Scientific and Practical Centre, Chief Oncologist in and for Moscow is now an honoured member of the American Surgical Association.

All news